Goodwin Procter·FDA / LIFE SCIENCES REGULATORY

FDA Issues FAQ Guidance for Cell and Gene Therapy

The US Food and Drug Administration has published a new guidance document answering frequently asked questions on the development of cellular and gene therapy products, covering topics from IND submissions to clinical trial design.

fdacgtgene-therapycell-therapyregulatory-guidancelife-sciencesdrug-development
Read the original firm alert → Tuesday, September 1, 2026

Stay ahead

Join the digest.

One email when the daily AmLaw 100 briefing ships. No noise, no pitch decks — just the grade 4–5 signal.